Next Article in Journal
Lipophilic Substances of the Leaves and Inflorescences of Centaurea scabiosa L.: Their Composition and Activity Against the Main Protease of SARS-CoV-2
Previous Article in Journal
Novel Ni/Zn MOFs for Sorbitol Production via Catalytic Transfer Hydrogenation
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Molecules
Volume 30
Issue 23
10.3390/molecules30234567
Due to scheduled maintenance work on our servers, there may be short service disruptions on this website between 11:00 and 12:00 CEST on March 28th.
molecules-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Enhancing the Catalytic Performance of β-Mannanase via Polyvinyl Alcohol Immobilization and Genipin Modification

by
Nazli Ece Varan Faki
1,
Ali Toprak
2,
Guzide Yucebilgic
1,
Dilek Alagöz
3,*,
Deniz Yildirim
1,4 and
Roberto Fernandez-Lafuente
5,*
1
Chemistry Department, Sciences & Letters Faculty, Cukurova University, Adana 01330, Turkey
2
Acigol Vocational School, Nevsehir Haci Bektas Veli University, Nevsehir 50140, Turkey
3
Imamoglu Vocational School, Cukurova University, Adana 01330, Turkey
4
Chemical Engineering Department, Engineering Faculty, Cukurova University, Adana 01330, Turkey
5
Departamento de Biocatalisis, ICP-CSIC, 28049 Madrid, Spain
*
Authors to whom correspondence should be addressed.
Molecules 2025, 30(23), 4567; https://doi.org/10.3390/molecules30234567
Submission received: 27 October 2025 / Revised: 24 November 2025 / Accepted: 26 November 2025 / Published: 27 November 2025
(This article belongs to the Special Issue Application of Bioenzyme Engineering and Enzyme Catalysis in the Food Industry)
Browse Figures
Versions Notes

Abstract

This study reports the immobilization of β-mannanase from Aspergillus niger—either unmodified or genipin-modified—within polyvinyl alcohol hydrogels (PVA@mannanase and PVA@mannanase-Gen) for the enhanced production of mannooligosaccharides (MOSs). All enzyme preparations showed an optimal pH of 5.0, while immobilization shifted the optimal temperature from 40 °C for the free enzyme to 55 °C for the immobilized forms. Genipin modification notably improved stability, increasing the half-life from 25.3 h (free enzyme) to 429.2 h in PVA@mannanase-Gen, and raised catalytic efficiency by approximately 2.3-fold. Both immobilized preparations retained over 75% of their activity after five reuse cycles at pH 5 and 55 °C. Using PVA@mannanase-Gen under these optimized conditions, MOSs were effectively produced, with mannotetraose as the predominant product. To explore their potential applications, the MOSs generated from locust bean gum were evaluated for effects on MCF-7 and HCT-116 cancer cell lines, resulting in moderate growth inhibition (~24–25% at 0.4 mM after 24 h). Together, these findings demonstrate that the immobilization of the genipin-modified enzyme not only enhances β-mannanase stability and performance but also supports the efficient production of MOSs with promising antitumoral activity.

Graphical Abstract

1. Introduction

Endo-1,4-mannanases (E.C. 3.2.1.78) are enzymes that catalyze the hydrolysis of the (1,4)-D-mannosidic linkages found in mannans and related heteropolysaccharides, such as galactomannans and glucomannans [1,2]. This enzymatic activity results in the production of smaller mannooligosaccharides, which are composed of 3–10 mannose residues. These enzymes play a significant role in the degradation of plant materials, making them important in various industrial applications, including food processing, animal feed, and biofuel production [3,4]. Their ability to break down complex carbohydrates can enhance the digestibility of feed and improve the yield of fermentable sugars in bioconversion processes [5,6]. However, the use of free enzymes for industrial applications can be limited by several factors, including instability at elevated temperatures, reduced activity at high substrate concentrations, susceptibility to inhibition by chemicals used in production, etc. [5]. To enhance their performance, modifications are often necessary prior to application. A widely adopted and practical solution to these issues is the immobilization of enzymes. An adequate use of this technique not only stabilizes enzymes under harsh conditions [7,8,9,10,11,12,13] but also allows their easier recovery and reuse [14], significantly improving their efficiency and effectiveness in various industrial processes [15,16,17,18]. Enzyme immobilization may be used for a final tuning of the enzyme features (selectivity, specificity, resistance to inhibitors) [19,20,21] or may be coupled to enzyme purification [22]. That way, enzyme immobilization is far more than a mere tool to recover and reuse the enzymes, but it is a last opportunity of tuning the enzyme features [23]. In the case of β-mannanase, these advantages are especially valuable because its industrial applications—such as biomass hydrolysis and mannooligosaccharide production—often require elevated temperatures, prolonged operation times, and exposure to viscous, inhibitor-rich substrate matrices. Consequently, various immobilization strategies—employing supports such as polymeric matrices, inorganic materials, biocompatible gels, and a wide range of nanomaterials—have been explored to enhance the robustness and efficiency of β-mannanases from different sources. Al Shimaa Gamal Shalaby et al. [24] immobilized mannanase from Penicillium chrysogenum in calcium alginate beads and reported that both the free and immobilized mannanase preparations successfully hydrolyzed locust bean gum to valuable mannooligosaccharides. Panwar et al. [25] prepared crosslinked enzyme aggregates (CLEAs) of endo-β-1,4-mannanase and demonstrated that the immobilized mannanase showed better pH and thermal stabilities than those of the free counterpart. Behera et al. [26] utilized the same immobilization strategy to immobilize crude β-mannanase and found that the prepared CLEAs were active over a broader pH range than the free enzyme. Sadaqat et al. [27] used glutaraldehyde crosslinked chitosan beads to immobilize β-mannanase and determined that the immobilized mannanase had a higher optimal temperature than the free enzyme. Dhiman et al. [28] immobilized partially purified β-mannanase on the modified matrix of sodium alginate-grafted β-cyclodextrin and showed that the immobilization increased the thermostability of the β-mannanase. Dikbaş et al. [29] immobilized mannanase from Bacillus invictae onto zinc oxide nanoparticles and determined that the immobilized mannanase preparation had positive effects on the germination parameters of tomatoes.
Polyvinyl alcohol (PVA) is a widely used polymer for enzyme and cell immobilization due to its affordability, ease of availability, hydrophilic nature, and the presence of surface hydroxyl groups [18,30,31,32,33,34]. These properties make PVA an excellent matrix for various biocatalysts [35,36]. Additionally, functionalizing PVA or combining it with other materials can further enhance the catalytic properties of the immobilized enzymes, improving their operational stability and overall performance in industrial applications. Such modifications can lead to increased enzyme activity, higher resistance to harsh conditions, and prolonged reusability, making PVA a versatile choice for enzyme immobilization [37,38].
Genipin is a naturally occurring crosslinking agent that facilitates the formation of three-dimensional networks by crosslinking molecules [39,40]. This crosslinking network formation enhances the stability and structural integrity of the materials used in various applications. The use of spacer arms plays a critical role in modulating the catalytic performance and stability of immobilized enzymes [41]. Flexible or multifunctional linkers such as (3-Aminopropyl)triethoxysilane (APTES), genipin, glutaraldehyde, and polyethyleneimine (PEI) reduce steric hindrance, improve the accessibility of active sites, and create a microenvironment that supports more native-like enzyme conformations [42]. Genipin is a safer and more biocompatible alternative to conventional crosslinking systems such as PEI, APTES, and glutaraldehyde. Unlike glutaraldehyde, genipin provides stable covalent networks with a significantly lower toxicity, making it more suitable for cell-compatible scaffolds and in vivo applications [27,43]. Although PEI offers dense amine functionality, it is highly cytotoxic and prone to non-specific interactions [44]. APTES is effective for silanizing inorganic surfaces; however, its hydrolytic instability and lack of true crosslinking capacity limit its usefulness in forming robust 3D networks [45]. Overall, while genipin crosslinking is slower and may result in blue pigmentation, its biocompatibility, controlled reactivity, and ability to stabilize natural polymers make it a superior choice for tissue engineering, hydrogel formation, and bioactive scaffold design [46,47].
Mannooligosaccharides (MOSs) may be produced through the enzymatic, alkaline, or acidic hydrolysis of cell wall mannans derived from different sources such as yeast (Saccharomyces cerevisiae) or vegetable galactomannans [48,49,50]. MOSs, which consist of linear chains of mannose, can be further classified into α- and β-MOSs. β-MOSs are primarily used as prebiotics in the poultry industry [50]. Recent studies indicate that MOSs may serve as an important functional food ingredient and hold potential applications as antioxidants and anti-cancer agents [51]. MOSs are reported to have prebiotic properties due to their resistance to digestion in the upper gastrointestinal tract [52]. Additionally, MOSs are noted for their potential antineoplastic (anti-cancer) properties, which may help to inhibit the growth of cancer cells [53]. Importantly, MOSs have been shown to exert these effects without causing cytotoxicity to normal, healthy cells, making them a promising natural compound for both gut health and cancer prevention [51].
MCF-7 cells (a human breast cancer cell line) are one of the most widely used cell lines in cancer research worldwide [54]. MCF-7 cells serve as a model for evaluating chemotherapeutic agents, targeted therapies, and novel anti-cancer drugs. Their responses to various agents can be measured through changes in cell proliferation, apoptosis, and migration, making them suitable for screening antitumoral drug candidates [55]. The HCT-116 cell line is a human colorectal carcinoma cell line also used in cancer research. It was derived from a primary colon adenocarcinoma tumor and has been extensively studied for its relevance in understanding colon cancer biology, drug development, and cellular mechanisms [56]. Pason et al. [57] showed that MOSs from coconut meal inhibit the apoptosis of HCT116 cells.
Although several immobilization strategies have been applied to β-mannanase, the existing approaches present several limitations. Many rely on harsh or potentially toxic crosslinkers such as glutaraldehyde, which can restrict biocompatibility and influence downstream applications, particularly when the target products—such as MOSs—are intended for food, nutraceutical, or biomedical uses. Moreover, while structural stabilization has been achieved, fewer studies have focused on immobilization methods that simultaneously enhance enzyme stability, catalytic efficiency, and product selectivity. The influence of immobilization on MOS composition, especially the targeted production of higher-value oligosaccharides, also remains insufficiently explored. In this context, genipin-based immobilization offers a promising alternative, combining effective crosslinking capacity with low toxicity, improved biocompatibility, and the potential to modulate enzyme microenvironments more gently than conventional agents. By integrating genipin modification with PVA hydrogel immobilization, the present study aims to address key gaps in the field—namely, achieving enhanced stability at elevated temperatures, improving catalytic efficiency, and employing a more sustainable and application-friendly immobilization strategy for the production of MOSs.
In this study, mannanase from Aspergillus niger was encapsulated in PVA (PVA@mannanase), and the obtained PVA@mannanase preparation was subjected to modification with genipin (PVA@mannanase/Gen). β-mannanase from A. niger was chosen due to its commercial availability, known high activity, and previous successful applications in MOS production [58,59]. All mannanase samples were characterized in terms of optimal pH, temperature, thermal stability, and kinetic parameters. Locust bean gum (LBG) hydrolysis reaction courses catalyzed by PVA@mannanase/Gen were monitored by determining the amount of reducing sugar, and the formed MOSs were determined using high-performance liquid chromatography. The produced MOSs were tested as inhibitors of the growth of cancer cells of MCF-7 and HCT-116 cell lines.

2. Results and Discussion

Table 1 shows the immobilization yields (%) and expressed activity (%) of PVA@mannanase and PVA@mannanase-Gen for different protein loadings. The immobilization yields were 100% for all assayed protein loadings in the range of 0.125–0.5 mg. The modification of the enzyme with genipin (2 g/L) produced an improvement of the immobilized enzyme activity at the three assayed loadings. The study of the activity of the free enzyme modified by genipin showed that this modification caused an increase in the activity of the enzyme in the range of 110–125%. This could be a consequence of the promotion of favorable changes in the enzyme structure caused by the modification, or of a stabilization of the enzyme, which permitted the modified enzyme to show a higher activity under the relatively harsh conditions utilized in the enzyme activity determination. This higher activity after genipin modification was transferred to an improved enzyme activity after the immobilization of the modified enzyme, which, when using 0.25 mg/mL, was even higher than the activity of the free and unmodified enzyme. Curiously, the highest expressed activities were determined at the intermedium enzyme loading (0.25 mg/mL) for the modified and unmodified immobilized enzyme preparations, reaching 86.6% and 119.2% of the offered enzyme activity for PVA@mannanase and PVA@mannanase-Gen, respectively, when the initial protein loading was 0.25 mg/mL. The higher expressed activity when the load increased from 0.125 to 0.25 mg/mL was not expected (as the substrate diffusional matter should produce an enzyme decrease in activity when the volumetric activity increases) [60,61,62], and may be due to diverse facts. One possibility is that the free enzyme may be more stable at higher concentration by forming enzyme aggregates. These enzyme aggregates may be more stable than the individual enzyme molecules, and they should be larger. After immobilization, if the enzyme aggregates are immobilized together with individual enzyme molecules, it is possible that the smaller individual enzyme molecules can be washed from the beads, while the larger enzyme aggregates remain immobilized. These aggregates can be more abundant or larger using higher enzyme concentrations, while aggregates that are too large can suffer from additional substrate diffusion limitations. Another possibility is the fact that the determination of the enzyme activity is based on the increase in reducing sugars, not the degradation of new mannan molecules. It is possible that the smaller fragments of the mannans may become better substrates than the intact polymer, and the enzyme molecules immobilized inside the particles can attack these fragments, producing a higher amount of reducing groups even with the modification of a lower amount of the mannan molecules [63]. The use of a further increased amount of enzyme can lead to an increase in the substrate diffusional limitations and produce a decrease in enzyme activity, even in the hypothetical case of a better hydrolysis of the smaller fragment of the polymer substrate. If this was the case, the use of the immobilized enzyme should produce a higher number of small MOSs at a lower initial mannan degradation. This possibility is currently under study in our research group.
The effect of genipin concentration used in the biocatalyst modification on the activity of PVA@mannanase-Gen was studied over a concentration range of 0.5–5.0 g/L. As illustrated in Figure 1, the activity of PVA@mannanase-Gen remained unaffected when the genipin concentration was increased from 0.5 to 1.0 g/L. However, when the genipin concentration was raised to 2.0 g/L, the highest activity was observed. Further increases in the genipin concentration led to a decrease in the enzyme activity, very likely by an excessive modification of the enzyme surface. According to these results, the selected genipin concentration used for the preparation of PVA@mannanase-Gen was 2 g/L.
FTIR spectra of PVA, PVA@mannanase, and PVA@mannanase-Gen are shown in Figure 2. The band around 3200–3600 cm−1 indicates the presence of hydroxyl groups from the PVA molecule. The peak at 2800–3000 cm−1 is attributed to the C-H stretching vibration from the PVA backbone. The peak at 1050–1150 cm−1 corresponds to the C-O stretching vibration, associated with the alcohol (-OH) groups in PVA [64]. After the immobilization of mannanase, the intensity of band around 3200–3600 cm−1 decreased. This may be due to the formation of hydrogen bonds between the free hydroxyl groups of PVA molecules and enzyme molecules. The peak produced using PVA@mannanase or PVA@mannanase-Gen around 1650 cm−1 is attributed to the amide I bond, indicating the presence of mannanase in the composite.
SEM images of PVA, PVA@mannanase, and PVA@mannanase-Gen may be found in Figure 3. The PVA surface was smooth, dense, and non-porous (Figure 3a,b), while PVA@mannanase and PVA@mannanase-Gen show a porous structure due to the interaction between the enzyme and the PVA (Figure 3c–f). This increase in porosity may cause the substrate molecule to be more accessible to the enzyme.
Next, the effect of the pH on the activity of free and immobilized β-mannanase preparations was analyzed. As illustrated in Figure 4A, the highest mannanase activity was recorded at pH 5.0 for all preparations. PVA@mannanase retained much more relative activity at a pH under 5 than PVA@mannanase-Gen or the free enzyme. PVA@mannanase-Gen retained more activity than the free enzyme at these acidic pH values. However, when the pH values were higher than 5, the relative activities of all preparations became very similar. It should be considered that PVA@mannanase-Gen was already significantly more active than the free enzyme, so the specific activity of the enzyme in this biocatalyst was much better than that of the free enzyme in all the studied pH ranges.
As illustrated in Figure 4B, the highest activity of free β-mannanase at pH 5.0 was determined at 40 °C, whereas the highest activities of PVA@mannanase and PVA@mannanase-Gen were both at 55 °C. Notably, the activities of PVA@mannanase and PVA@mannanase-Gen were less affected by the temperature change compared to the free enzyme in the temperature range of 30–60 °C, highlighting the protective benefits of the immobilization process for the mannanase activity. The optimum pH for both forms of the Man/Cel5B enzyme was found to be pH 5.5. The optimum pH and temperature of both free β-mannanase and its immobilized form on the zinc oxide nanoparticle were 6.0 and 40 °C, respectively [29]. Blibech et al. [65] reported that the optimal pH of β-mannanase produced from five soil-derived Bacillus strains was 5.0, and the optimal temperature was in the range of 50–70 °C. Zhao et al. [66] found that the optimal pH and temperature of β-mannanase purified from Lactobacillus casei HDS-01 were 5.0 and 40 °C, respectively.
Next, the thermal stability of free mannanase, PVA@mannanase, and PVA@mannanase-Gen was examined at 40 °C and 55 °C for 24 h (Figure 4C,D). The results indicated that PVA@mannanase and PVA@mannanase-Gen retained 95% and 100% of their initial activity after 24 h of incubation at 40 °C. However, the retained activity for the free mannanase was 66% of its initial activity under the same conditions. At 55 °C, the activity of free mannanase decreased significantly, and the retained activity was approximately 27% after 24 h of incubation. However, PVA@mannanase and PVA@mannanase-Gen remained almost fully active after this incubation (90% and 95%, respectively). These findings clearly demonstrate that the immobilized β-mannanase exhibits enhanced stability. This also may explain the significant increase in the optimal temperature at pH 5.0 detected for these immobilized biocatalysts. Moreover, the modification of PVA@mannanase with genipin resulted in a new increase in thermal stability, perhaps by achieving an inter-molecular crosslinking. Shalaby et al. [24] immobilized partially purified mannanase from Penicillium chrysogenum in calcium alginate beads and reported that the immobilized mannanase was about 2-fold more thermostable than the free mannanase at 70 °C. Anderson et al. [67] showed that the retained activities of both the free and immobilized mannanase were similar after 10 h incubation at 60 °C (approximately 75%).
The kinetic parameters for the free and immobilized β-mannanase preparations towards LBG are presented in Table 2. The apparent Km values for the free enzyme, PVA@mannanase, and PVA@mannanase-Gen were found to be 25.8 ± 0.04, 69.6 ± 0.05, and 14.0 ± 0.03 mg mL−1, respectively. The corresponding Vmax values were 55.0 ± 0.07, 34.4 ± 0.08, and 68.9 ± 0.06 U/mg protein. The kcat values were calculated to be 44.0, 27.5, and 55.1 min−1 for the free enzyme, PVA@mannanase, and PVA@mannanase-Gen, respectively. The corresponding kcat/Km values were 1.7, 0.4, and 3.9 s−1 mg−1 mL. According to these results, the catalytic efficiency values were calculated to be 0.24 and 2.30 comparing the free enzyme and PVA@mannanase or PVA@mannanase-Gen, respectively. PVA@mannanase shows a worsening of both the Km (more significant) and kcat compared to the free enzyme. However, PVA@mannanase-Gen shows a significant increase in efficiency compared to the free enzyme or the unmodified immobilized enzyme, because both Km (more intensely) and kcat are improved after genipin modification. As the unmodified immobilized enzyme did not improve the Km, the positive partition of the substrate can be discarded as the main cause for the improved Km of the genipin-modified enzyme. The enhanced catalytic efficiency of PVA@mannanase-Gen arises from genipin-induced conformational stabilization and an improved microenvironment within the PVA matrix. Genipin modification seems to induce a positive conformational change in the enzyme structure, lowering the Km and increasing kcat, resulting in an approximately 9.6-fold increase in catalytic efficiency compared to the unmodified enzyme. Anderson et al. [67] covalently immobilized endo-1,4-β-mannanase from Aspergillus niger on glutaraldehyde-activated chitosan nanoparticles, and the Km and Vmax values were 8.44 mg/mL and 55.36 U/mg protein, respectively. These values corresponded to 7.74 mg/mL and 12.10 U/mg protein for its immobilized counterpart. Panwar et al. [25] prepared the crosslinked aggregated (MB-C) and chitosan magnetic nanocomposites of MB-C (MB-Mag-C), forms of recombinant endo-β-1,4-mannanase. The Km and Vmax values of MB-C were found to be 8.1 mg/mL and 135 U/mg protein, respectively. These values for MB-Mag-C were correspondingly 6.7 mg/mL and 67.1 U/mg protein. The Km values of free and immobilized NaAlg-β-CD-β-mannanase were determined to be 25 and 36 mg/mL. The corresponding Vmax values were 2500 and 2252.25 U/mg protein [28]. The Km values were found to be 10.2 and 19.4 mg/mL for the free β-mannanase and Man-CaAlg, respectively. The Vmax values were correspondingly 3.24 and 6.17 U/mg protein [68]. The Km values of the free and immobilized Man/Cel5B were found to be 10.7 mg/mL and 4.8 mg/mL, respectively. Furthermore, the Vmax values of free and chitosan-immobilized Man/Cel5B were found to be 106 and 2.56 U/mg protein [27]. Compared to the other immobilized β-mannanases given in Table 2, PVA@mannanase-Gen exhibits a superior catalytic efficiency, reflected in its lower Km and higher Vmax. Unlike other immobilization methods, this approach minimizes steric hindrance and denaturation, enhancing both substrate binding and turnover. Together, these factors enable PVA@mannanase-Gen to outperform previously reported immobilized β-mannanases.
Figure 5 shows the operational stability of PVA@mannanase and PVA@mannanase-Gen for five consecutive reuses. The residual activity of both PVA@mannanase and PVA@mannanase-Gen slightly decreased with an increasing reuse number. After five reuses, the residual activities were 75% and 79% of the initial activity of PVA@mannanase and PVA@mannanase-Gen, respectively. This decrease in biocatalyst activity may be due to enzyme inactivation, the loss of some biocatalyst mass after each reuse in the filter, enzyme release from the biocatalyst, or the accumulation in the beads of some substances that can act as enzyme inhibitors. In the case of PVA-based hydrogels, an additional factor may be the partial clogging of pores by the large LBG substrate and intermediate hydrolysis products, which can create diffusion barriers and progressively restrict substrate access to the immobilized enzyme during repeated cycles. Chen et al. [60] reported that CaAlg maintained 70.34% of its initial activity after eight reuses. MB-C and MB-Mag-C were used to hydrolyze LBG for 12 cycles, and MB-C and MB-Mag-C retained 31.08% and 8.6% of their initial activities at the end of 12 cycles [25]. Dhiman et al. demonstrated that 70% of the residual activity was retained after 15 repeated cycles for β-mannanase immobilized on the modified matrix of sodium alginate-grafted β-cyclodextrin [28]. Sadaqat et al. [27] reported that β-mannanase immobilized on glutaraldehyde crosslinked chitosan beads remained at 70% of its initial activity after 15 uses. Compared with the examples in the literature, PVA@mannanase and PVA@mannanase-Gen have a good reusability.
The time-course hydrolysis of LGB catalyzed by PVA@mannanase-Gen is shown in Figure 6A. The total amount of the MOS concentration was calculated to be 0.176 ± 0.03 mM after 1 h of hydrolysis time and linearly increased to 0.348 ± 0.05 mM at the end of 2 h of hydrolysis time. The total amount of MOSs was determined to be 0.40 mM after 6 h of reaction time, and an increase in reaction time (8 h) did not change the total MOS concentration. The MOS productivity of PVA@mannanase-Gen was calculated to be 0.05 mM/h. The products of the PVA@mannanase-Gen hydrolysis of LBG at different reaction times were also analyzed using the HPLC-RID technique. The retention times of mannose, mannobiose, mannotriose, and mannotetraose were 8.73, 9.73, 10.77, and 12.19 min. After 8 h of reaction time, the main formed MOS was mannotetraose. The yield of mannotetraose was approximately 63.7% of the total MOS amount. The yields of mannose, mannobiose, and mannotriose corresponded to 4.1%, 11.6%, and 20.6% of the total MOS amount, respectively (Figure 6B). The concentrations of mannose, mannobiose, mannotriose, and mannotetraose were approximately 0.016, 0.046, 0.08, and 0.25 mM, respectively. Chauhan et al. [69] showed that the major detected products of LBG hydrolysis catalyzed by free β-mannanase from Bacillus nealsonii PN-11 were mannobiose (11%), mannotriose (23%), mannotetrose (20%), and mannopentose (18%). According to the study by Sachslehner et al. [70], the mannanase from Sclerotium rolfsii generated mannooligosaccharides, including mannobiose, mannotriose, and mannotetrose. Rana et al. [71] reported that the yields of mannobiose (M2), mannotriose (M3), mannotetrose (M4), mannopentose (M5), mannohexose (M6), and mannoheptose (M7) were 28.9%, 23.3%, 10.6%, 15.9%, 13.2%, and 8.2%, respectively, for the hydrolysis of copra meal catalyzed by mannanase from Bacillus subtilis after 6 h of reaction time at pH 7.5 and 50 °C. Erkan et al. [72] calculated the amounts of M2, M3, M4, M5, and M6 as 1.86, 2.02, 0.70, 0.44, and 1.49 mM, respectively, from coffee extract after 90 min of reaction time at 40 °C using a recombinant Aspergillus sojae β-mannanase.
Various concentrations of LBG hydrolyzates ranging from 0 to 0.4 mM were used to treat MCF-7 and HCT-116 cell lines. As shown in Figure 7, the cell viability decreased when the amount of MOSs increased. For the 0.133 mM MOS concentration, cell growth inhibition was approximately 12% and 10% for MCF-7 and HCT-116 cell lines, respectively. When 0.4 mM MOS was used, the highest inhibition was observed as 24% and 25% for MCF-7 and HCT-116 cell lines, respectively. Ghosh et al. [53] reported that copra meal-derived MOSs at a concentration of 500 μg/mL reduced the survival of HT29 cells by 50%. Similarly, guar gum hydrolysate demonstrated anti-cancer properties, decreasing the viability of Caco-2 cells by 30.95% at the same concentration. Konjac gum oligosaccharides, primarily composed of M4, induced a 30% cell death at a concentration of 1000 μg/mL. Additionally, konjac glucomannan inhibited Hep G2 cells by modulating the Bcl-2/Bax protein pathway, resulting in an altered Bax/Bcl-2 ratio [73].

3. Materials and Methods

3.1. Materials

Endo-1,4-β-Mannanase from Aspergillus niger was obtained from Megazyme (Bray, Ireland). Polyvinyl alcohol (PVA, Mw 89,000–98,000), locust bean gum (LBG), and 3,5-dinitro salicylic acid (DNS) were purchased from Sigma Aldrich (St. Louis, MO, USA). Genipin was obtained from BLDpharm (Songjiang, China). All reagents were of analytical grade and used without further purification.

3.2. Mannanase Assay

To evaluate mannanase activity, LBG was used as substrate. The main backbone of LBG is composed of β-(1→4)-linked D-mannose units, and its side chains include single-unit α-(1→6)-linked D-galactose branches. Briefly, 50 µL of the enzyme solution was combined with 250 µL of a 0.25% (w/v) LBG solution prepared in 100 mM sodium acetate at pH 5.0 and incubated at 40 °C for 15 min [68]. Following this incubation, 300 µL of DNS was added, and the mixture was boiled for 10 min. After cooling to room temperature, the solution was diluted to a final volume of 4.0 mL with distilled water, and the absorbance was measured at 540 nm. A control was prepared using the same procedure but substituting the reaction solution with an equivalent volume of LBG solution. To measure the activity of immobilized enzymes, approximately 7 mg of the encapsulated enzyme was added to the reaction tube. Mannose equivalents were determined using a standard curve for reducing sugar concentration. One unit (IU) of mannanase activity was defined as μmol of released mannose per minute under the specified assay conditions.

3.3. Immobilization of Mannanase

The immobilization of mannanase was performed through entrapment in PVA gel, following the protocol described by Toprak et al. [74]. A 10% PVA solution was prepared in a glass bottle and then heated in a water bath at 90 °C. After cooling this solution to room temperature, 1 mL of mannanase (0.25 mg protein/mL in 100 mM sodium phosphate at pH 7.0) was added to 2 mL of the PVA solution at 25 °C. Subsequently, samples of 100 µL of the resulting mixture were deposited onto a rigid polystyrene surface for developing gelation. The solid gel particles (PVA@mannanase) were washed with 0.1 M sodium phosphate at pH 7.0 and then stored overnight at 5 °C until use. In some instances, 1 g/L (w/v) genipin solid was dissolved in the enzyme solution prior to combining it with the PVA solution (PVA@mannanase-Gen), thereby repeating the same procedure as before.
The immobilization yield and expressed activity were calculated as described by Boudrant et al. [75].

3.4. Fourier Transform Infrared Spectroscopy and Scanning Electron Microscopy Analysis

Fourier transform infrared spectroscopy (FTIR) analysis was performed using the Attenuated Total Reflectance (ATR) technique on PVA (control), PVA@mannanase, and PVA@mannanase-Gen. Spectra were recorded in the range of 500–4000 cm−1 using a Perkin Elmer Spectrum 100 FT-IR spectrometer. The instrument was equipped with a ZnSe/diamond sampling module and a single reflection detector, operating at room temperature. A total of 32 scans were collected for each spectrum at a resolution of 4 cm−1.
The surface morphology of PVA (control), PVA@mannanase, and PVA@mannanase-Gen was examined using scanning electron microscopy (SEM, Quanta 650 Field Emission SEM). To reduce charging effects, the samples were coated with a thin gold layer. The SEM was operated at 15 kV, and images were captured at various magnifications ranging from 5000× to 50,000×.

3.5. Effects of pH and Temperature on the Activity of the Different Enzyme Preparations

The effect of pH on free and immobilized mannanase activity preparations was assessed across a range of pH values from 3.0 to 6.0, using 100 mM sodium acetate at a constant temperature of 40 °C. Moreover, the influence of the temperature on enzyme activity was examined in the temperature range of 30–60 °C at pH 5.0, under standard assay conditions. The maximum activity observed within these specific pH and temperature ranges was designated as 100%, and the activities at all other corresponding pH values and temperatures were expressed relative to this baseline activity.

3.6. Enzyme Kinetic Parameters

The kinetic parameters of both free and immobilized mannanase samples were assessed by testing various substrate concentrations of LBG, ranging from 0.1 to 5 mg/mL, at optimal pH and temperature conditions. The apparent Michaelis–Menten constants (Km) and maximum activity (Vmax) were determined from the resulting Michaelis–Menten plot.

3.7. Thermal Stability

The thermal stability of free and immobilized mannanase samples was assessed by incubating them at 40 °C and 55 °C in 100 mM sodium acetate at their optimum pH. At specified time intervals, aliquots of the inactivation mixtures were taken to measure the enzyme activity under optimal conditions. The residual activity was calculated as the percentage of activity at each inactivation time point relative to the initial enzyme activity, allowing for a comparison of thermal stability between the free and immobilized forms of mannanase.

3.8. Reusability of Immobilized Mannanase Samples

The reusability of immobilized mannanase samples was evaluated in a batch-type reactor. Ten milligrams of immobilized mannanase were incubated in 1 mL of 100 mM sodium acetate (pH 5.0) under optimal activity conditions. The reaction was initiated by adding 400 µL of LBG at a concentration of 1 mg/mL. After 15 min of the reaction, the immobilized mannanase samples were removed from the reaction medium, and the resulting product solution was analyzed at 540 nm using an activity assay. To prepare the samples for subsequent cycles, the immobilized mannanase was washed with distilled water.

3.9. Time-Course Hydrolysis of LBG and Analysis of the Reaction Products

Five milligrams of PVA@mannanase-Gen were mixed with 1 mL of 0.25% (w/v) LBG. The reaction was performed in 100 mM sodium acetate at pH 5.0 and 55 °C under agitation of 100 rpm for different times (1–8 h). The amount of reducing sugar was determined using DNSA method.
The hydrolysate after 8 h of reaction time was separated from the biocatalysts through filtration using 0.45 μm nylon filters to ensure the removal of all biocatalyst residues. Samples of 20 μL of filtrate were taken out and analyzed by high-performance liquid chromatography coupled with a refractive index detector (HPLC-RID). The separation of reaction products was achieved on a Supelcosil LC-NH2 (5 μm particle size, L × I.D. 25 cm × 4.6 mm) column at 40 °C. A mixture of acetonitrile/water (75/25, v/v) was used as the mobile phase at a flow rate of 0.5 mL/min. All experiments have been repeated in triplicate.

3.10. Breast and Colorectal Carcinoma Cell Cultures

MCF-7 cells were cultured in a DMEM culture medium with 10% FBS and 1% penicillin/streptomycin antibiotic in a 25 cm2 cell culture flask in an incubator at 37 °C in an atmosphere containing 95% humidity and 5% CO2. Moreover, HTC-116 cells were cultured in a mixture of DMEM and F12 in equal ratio, supplemented with 5% heat-inactivated FBS, 1% L-glutamine, and 1% penicillin-streptomycin antibiotic in a 25 cm2 cell culture flask in an incubator at 37 °C in an atmosphere containing 95% humidity and 5% CO2. When the cells achieved an 80% uptake, they were trypsinized, resuspended, and transferred to a 75 cm2 cell culture flask. Cell counting was performed with trypan blue [76]. Phase-contrast microscopy (Thermo Fisher Scientific, Evos XL Core, Oxford, UK) was used to evaluate the appearance of the cells. At the 80% confluency, the cells were trypsinized, resuspended, and counted to assess cell density. Cells were inspected under a phase-contrast microscope to evaluate their appearance.

3.11. Assessment of Cell Survival by CCK-8 Method

MCF-7 and/or HCT-116 cells were seeded into 96-well plates containing 200 μL of DMEM and cultured for about 24 h in an incubator at 37 °C in an atmosphere containing 95% humidity and 5% CO2 [77]. The hydrolysate obtained from PVA@mannanase-Gen-catalyzed hydrolysis of LBG after 6 h of reaction time was separated from the biocatalysts through filtration using 0.45 μm nylon filters and used as MOS source. A 100 µL volume of the solution was added to the wells at different MOS concentrations (0.0–0.4 mM) and was placed in the incubator under the same conditions. At the end of 24 h, 100 µL of the medium was taken and transferred to a new plate. Then, 100 µL of fresh medium and 20 µL of CCK-8 solution were added and kept in the incubator for 4 h. Optical density (OD) at 450 nm was obtained with a microplate reader (BioTek, Epoch2 microplate Reader, MA, USA). The culture medium and CCK-8 were used as a blank, and untreated MCF-7 or HCT-116 cells were used as a control. Cell viability was then calculated by comparing the absorbance of treated samples to that of control (untreated) samples, typically using the following formula:
C e l l   v i a b i l i t y   %   =   ( A t   −   A b ) ( A c   −   A b )   ×   100
where At, Ac, and Ab are the absorbances of the treated sample, control sample, and blank sample at 450 nm, respectively.

3.12. Statistical Analysis

All experiments were performed in triplicate. Statistical analysis was conducted using analysis of variance (ANOVA) to determine significant differences among experimental groups. Group means were compared using the Least Significant Difference (LSD) method in SigmaPlot software (Version 12), with a significance level set at p < 0.05.

4. Conclusions

Mannanase from A. niger was immobilized in PVA, and the obtained immobilized mannanase was further treated with genipin. The enzyme optimal pH did not change after immobilization, whereas the immobilization of mannanase resulted in an increase in the optimal temperature from 40 °C to 55 °C at pH 5.0. PVA@mannanase-Gen exhibited a 2.3-fold higher catalytic efficiency compared to the free enzyme. After five reuses, at least 75% of the initial activity remained for the immobilized mannanase preparations. The MOS produced under these conditions showed moderate antiproliferative effects against MCF-7 and HCT-116 cells after 24 h; however, these preliminary in vitro observations require further mechanistic studies and in vivo validation before any therapeutic potential can be established. In conclusion, the immobilization of mannanase in PVA and subsequent treatment with genipin enhanced its thermal stability, catalytic efficiency, and reusability. However, although PVA–genipin systems offer a good biocompatibility and enzyme stabilization, they also present limitations. PVA’s high hydrophilicity can cause excessive water retention and swelling, reducing the mechanical strength and potentially affecting enzyme retention. Genipin, while safer than other crosslinker agents, displays slow reaction kinetics, which may lead to long biocatalyst preparation times and less uniform network formation. To overcome these drawbacks, alternative strategies include blending PVA with polymers with a lower tendency to swell (e.g., chitosan, alginate, or cellulose derivatives) and incorporating inorganic fillers to enhance rigidity. If the biocompatibility and low toxicity are not strict requirements (e.g., in an energy production process), faster or dual-crosslinking systems may be used.

Author Contributions

Conceptualization, G.Y. and D.Y.; methodology, D.A. and R.F.-L.; validation, formal analysis, A.T. and N.E.V.F.; investigation, A.T. and N.E.V.F.; data curation, D.Y.; writing—original draft preparation, D.A. and D.Y.; writing—review and editing, R.F.-L. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by Agencia Estatal de Investigación (Spain), grant number PID2022-136535OB-I00.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

The data presented in this study are available on request from the corresponding author.

Conflicts of Interest

The authors declare no conflicts of interest.

Abbreviations

The following abbreviations are used in this manuscript:
APTES (3-Aminopropyl)triethoxysilane
FTIRFourier transform infrared spectroscopy
HTC-116Human colon cancer cell
kcatTurnover number
KmMichaelis–Menten constant
MCF-7Human breast cancer cell
MOSMannooligosaccharide
PEIPolyethyleneimine
PVAPolyvinyl alcohol
PVA@mannanaseImmobilized mannanase in polyvinyl alcohol hydrogel
PVA@mannanase-GenImmobilized mannanase modified with genipin
in polyvinyl alcohol hydrogel
SEMScanning electron microscopy
VmaxMaximum velocity

References

  1. Zhou, T.; Ju, X.; Yan, L.; Fang, R.; Xu, X.; Li, L. Production of mannooligosaccharides from orange peel waste with β-mannanase expressed in Trichosporonoides oedocephalis. Bioresour. Technol. 2024, 395, 130373. [Google Scholar] [CrossRef]
  2. Wang, N.-N.; Liu, J.; Li, Y.-X.; Ma, J.-W.; Yan, Q.-J.; Jiang, Z.-Q. High-level expression of a glycoside hydrolase family 26 β-mannanase from Aspergillus niger in Pichia pastoris for production of partially hydrolysed fenugreek gum. Process Biochem. 2021, 100, 90–97. [Google Scholar] [CrossRef]
  3. Jana, U.K.; Suryawanshi, R.K.; Prajapati, B.P.; Soni, H.; Kango, N. Production optimization and characterization of mannooligosaccharide generating β-mannanase from Aspergillus oryzae. Bioresour. Technol. 2018, 268, 308–314. [Google Scholar] [CrossRef] [PubMed]
  4. Favaro, C.P.; Baraldi, I.J.; Casciatori, F.P.; Farinas, C.S. β-Mannanase production using coffee industry waste for application in soluble Coffee processing. Biomolecules 2020, 10, 227. [Google Scholar] [CrossRef] [PubMed]
  5. Chauhan, P.S.; Puri, N.; Sharma, P.; Gupta, N. Mannanases: Microbial sources, production, properties and potential biotechnological applications. Appl. Microbiol. Biotechnol. 2012, 93, 1817–1830. [Google Scholar] [CrossRef] [PubMed]
  6. Tang, C.-D.; Li, J.-F.; Wei, X.-H.; Min, R.; Gao, S.-J.; Wang, J.-Q.; Yin, X.; Wu, M.-C. Fusing a carbohydrate-binding module into the Aspergillus usamii β-Mannanase to improve its thermostability and cellulose-binding capacity by in silico design. PLoS ONE 2013, 8, e64766. [Google Scholar] [CrossRef]
  7. Mateo, C.; Palomo, J.M.; Fernandez-Lorente, G.; Guisan, J.M.; Fernandez-Lafuente, R. Improvement of enzyme activity, stability and selectivity via immobilization techniques. Enzyme Microb. Technol. 2007, 40, 1451–1463. [Google Scholar] [CrossRef]
  8. Hwang, E.T.; Gu, M.B. Enzyme stabilization by nano/microsized hybrid materials. Eng. Life Sci. 2013, 13, 49–61. [Google Scholar] [CrossRef]
  9. Bommarius, A.S.; Paye, M.F. Stabilizing biocatalysts. Chem. Soc. Rev. 2013, 42, 6534–6565. [Google Scholar] [CrossRef]
  10. Iyer, P.V.; Ananthanarayan, L. Enzyme stability and stabilization-Aqueous and non-aqueous environment. Process Biochem. 2008, 43, 1019–1032. [Google Scholar] [CrossRef]
  11. Sheldon, R.A.; van Pelt, S. Enzyme immobilisation in biocatalysis: Why, what and how. Chem. Soc. Rev. 2013, 42, 6223–6235. [Google Scholar] [CrossRef]
  12. Polizzi, K.M.; Bommarius, A.S.; Broering, J.M.; Chaparro-Riggers, J.F. Stability of biocatalysts. Curr. Opin. Chem. Biol. 2007, 11, 220–225. [Google Scholar] [CrossRef] [PubMed]
  13. Rodrigues, R.C.; Berenguer-Murcia, Á.; Carballares, D.; Morellon-Sterling, R.; Fernandez-Lafuente, R. Stabilization of enzymes via immobilization: Multipoint covalent attachment and other stabilization strategies. Biotechnol. Adv. 2021, 52, 107821. [Google Scholar] [CrossRef] [PubMed]
  14. Di Cosimo, R.; Mc Auliffe, J.; Poulose, A.J.; Bohlmann, G. Industrial use of immobilized enzymes. Chem. Soc. Rev. 2013, 42, 6437–6474. [Google Scholar] [CrossRef]
  15. Özdemir, F.İ.; Karaaslan, B.; Tülek, A.; Yucebilgic, G.; Yildirim, D. Immobilization of recombinant l-asparaginase from Geobacillus kaustophilus on magnetic MWCNT-nickel composites. Process Biochem. 2023, 127, 10–20. [Google Scholar] [CrossRef]
  16. Rodríguez-Restrepo, Y.A.; Orrego, C.E. Immobilization of enzymes and cells on lignocellulosic materials. Environ. Chem. Lett. 2020, 18, 787–806. [Google Scholar] [CrossRef]
  17. Kujawa, J.; Głodek, M.; Li, G.; Al-Gharabli, S.; Knozowska, K.; Kujawski, W. Highly effective enzymes immobilization on ceramics: Requirements for supports and enzymes. Sci. Total Environ. 2021, 801, 149647. [Google Scholar] [CrossRef]
  18. Maghraby, Y.R.; El-Shabasy, R.M.; Ibrahim, A.H.; Azzazy, H.M.E.-S. Enzyme immobilization technologies and industrial applications. ACS Omega 2023, 8, 5184–5196. [Google Scholar] [CrossRef]
  19. Garcia-Galan, C.; Berenguer-Murcia, A.; Fernandez-Lafuente, R.; Rodrigues, R.C. Potential of different enzyme immobilization strategies to improve enzyme performance. Adv. Synth. Catal. 2011, 353, 2885–2904. [Google Scholar] [CrossRef]
  20. Rodrigues, R.C.; Ortiz, C.; Berenguer-Murcia, Á.; Torres, R.; Fernández-Lafuente, R. Modifying enzyme activity and selectivity by immobilization. Chem. Soc. Rev. 2013, 42, 6290–6307. [Google Scholar] [CrossRef]
  21. Khan, M.F.; Kundu, D.; Gogoi, M.; Shrestha, A.K.; Karanth, N.G.; Patra, S. Enzyme-responsive and enzyme immobilized nanoplatforms for therapeutic delivery: An overview of research innovations and biomedical applications. In Nanopharmaceuticals: Principles and Applications; Yata, V.K., Ranjan, S., Dasgupta, N., Lichtfouse, E., Eds.; Springer International Publishing: Cham, Switzerland, 2020; Volume 3, pp. 165–200. [Google Scholar]
  22. Barbosa, O.; Ortiz, C.; Berenguer-Murcia, Á.; Torres, R.; Rodrigues, R.C.; Fernandez-Lafuente, R. Strategies for the one-step immobilization-purification of enzymes as industrial biocatalysts. Biotechnol. Adv. 2015, 33, 435–456. [Google Scholar] [CrossRef] [PubMed]
  23. Bolivar, J.M.; Woodley, J.M.; Fernandez-Lafuente, R. Is enzyme immobilization a mature discipline? Some critical considerations to capitalize on the benefits of immobilization. Chem. Soc. Rev. 2022, 51, 6251–6290. [Google Scholar] [CrossRef]
  24. Esawy, M.A.; Hussein, M.D.M. Comparative study between free and immobilized Penicillium chrysogenum mannanase: A local fungal isolate. Pharm. Sci. 2017, 7, 97–104. [Google Scholar]
  25. Panwar, D.; Kaira, G.S.; Kapoor, M. Cross-linked enzyme aggregates (CLEAs) and magnetic nanocomposite grafted CLEAs of GH26 endo-β-1,4-mannanase: Improved activity, stability and reusability. Int. J. Biol. Macromol. 2017, 105, 1289–1299. [Google Scholar] [CrossRef] [PubMed]
  26. Behera, S.; Dev, M.J.; Singhal, R.S. Cross-linked β-mannanase aggregates: Preparation, characterization, and application for producing partially hydrolyzed guar gum. Appl. Biochem. Biotechnol. 2022, 194, 1981–2004. [Google Scholar] [CrossRef]
  27. Sadaqat, B.; Sha, C.; Dar, M.A.; Dhanavade, M.J.; Sonawane, K.D.; Mohamed, H.; Shao, W.; Song, Y. Modifying thermostability and reusability of hyperthermophilic mannanase by immobilization on glutaraldehyde cross-linked chitosan beads. Biomolecules 2022, 12, 999. [Google Scholar] [CrossRef]
  28. Dhiman, S.; Srivastava, B.; Singh, G.; Khatri, M.; Arya, S.K. Immobilization of mannanase on sodium alginate-grafted-β-cyclodextrin: An easy and cost effective approach for the improvement of enzyme properties. Int. J. Biol. Macromol. 2020, 156, 1347–1358. [Google Scholar] [CrossRef] [PubMed]
  29. Dikbaş, N.; Alım, Ş.; Uçar, S.; Çepni, E. Immobilization of mannanase enzyme to ZnO nanoparticle and determination of its effect on tomato seed germination. J. Soil Sci. Plant Nutr. 2023, 23, 5683–5694. [Google Scholar] [CrossRef]
  30. Chapman, J.; Ismail, A.E.; Dinu, C.Z. Industrial applications of enzymes: Recent advances, techniques, and outlooks. Catalysts 2018, 8, 238. [Google Scholar] [CrossRef]
  31. Bajić, M.; Plazl, I.; Stloukal, R.; Žnidaršič-Plazl, P. Development of a miniaturized packed bed reactor with ω-transaminase immobilized in LentiKats®. Process Biochem. 2017, 52, 63–72. [Google Scholar] [CrossRef]
  32. Krasňan, V.; Stloukal, R.; Rosenberg, M.; Rebroš, M. Immobilization of cells and enzymes to LentiKats®. Appl. Microbiol. Biotechnol. 2016, 100, 2535–2553. [Google Scholar] [CrossRef] [PubMed]
  33. Jekel, M.; Buhr, A.; Willke, T.; Vorlop, K.D. Immobilization of biocatalysts in LentiKats. Chem. Eng. Technol. 1998, 21, 275–278. [Google Scholar] [CrossRef]
  34. Rebroš, M.; Rosenberg, M.; Mlichová, Z.; Krištofíková, L.; Paluch, M. A simple entrapment of glucoamylase into LentiKats® as an efficient catalyst for maltodextrin hydrolysis. Enzym. Microb. Technol. 2006, 39, 800–804. [Google Scholar] [CrossRef]
  35. Guajardo, N. Immobilization of lipases using poly(vinyl) alcohol. Polymers 2023, 15, 2021. [Google Scholar] [CrossRef]
  36. Hasbek, F.M.; Yildirim, D. Entrapment of protease from Bacillus sp. in polyvinyl alcohol hydrogels. Eur. Chem. Biotechnol. J. 2025, 3, 21–31. [Google Scholar] [CrossRef]
  37. Yue, C.; Wang, J.; Wu, D.; Wang, Z.; Wang, G. Immobilization of phospholipase A1 on polyvinyl alcohol microspheres to develop a time-temperature indicator for freshness monitoring of pork. J. Food Eng. 2023, 357, 111640. [Google Scholar] [CrossRef]
  38. Amani, A.; Kalajahi, S.T.; Yazdian, F.; Mirzababaei, S.; Rashedi, H.; Faramarzi, M.A.; Vahidi, M. Immobilization of urease enzyme on chitosan/polyvinyl alcohol electrospun nanofibers. Biotechnol. Prog. 2022, 38, e3282. [Google Scholar] [CrossRef]
  39. Ahmed, R.; ul ain Hira, N.; Wang, M.; Iqbal, S.; Yi, J.; Hemar, Y. Genipin, a natural blue colorant precursor: Source, extraction, properties, and applications. Food Chem. 2024, 434, 137498. [Google Scholar]
  40. Kahoush, M.; Behary, N.; Guan, J.; Cayla, A.; Mutel, B.; Nierstrasz, V. Genipin-mediated immobilization of glucose oxidase enzyme on carbon felt for use as heterogeneous catalyst in sustainable wastewater treatment. J. Environ. Chem. Eng. 2021, 9, 105633. [Google Scholar] [CrossRef]
  41. Khan, M.F.; Kundu, D.; Hazra, C.; Patra, S. A strategic approach of enzyme engineering by attribute ranking and enzyme immobilization on zinc oxide nanoparticles to attain thermostability in mesophilic Bacillus subtilis lipase for detergent formulation. Int. J. Biol. Macromol. 2019, 136, 66–82. [Google Scholar] [CrossRef]
  42. Robescu, M.S.; Bavaro, T. A comprehensive guide to enzyme immobilization: All you need to know. Molecules. 2025, 30, 939. [Google Scholar] [CrossRef]
  43. Tacias-Pascacio, V.G.; García-Parra, E.; Vela-Gutiérrez, G.; Virgen-Ortiz, J.J.; Berenguer-Murcia, Á.; Alcántara, A.R.; Fernandez-Lafuente, R. Genipin as an emergent tool in the design of biocatalysts: Mechanism of reaction and applications. Catalysts 2019, 9, 1035. [Google Scholar] [CrossRef]
  44. Ismail, A.; Chou, S.-F. Polyethylenimine carriers for drug and gene delivery. Polymers 2025, 17, 2150. [Google Scholar] [CrossRef]
  45. Zhu, M.; Lerum, M.Z.; Chen, W. How to prepare reproducible, homogeneous, and hydrolytically stable aminosilane-derived layers on silica. Langmuir 2012, 28, 416–423. [Google Scholar] [CrossRef]
  46. Piaia, L.; Silva, S.S.; Fernandes, E.M.; Gomes, J.M.; Franco, A.R.; Leonor, I.B.; Fredel, M.C.; Salmoria, G.V.; Hotza, D.; Reis, R.L. Chitosan-based hierarchical scaffolds crosslinked with genipin. J. Compos. Sci. 2024, 8, 85. [Google Scholar] [CrossRef]
  47. Wang, L.; Ding, X.; He, X.; Tian, N.; Ding, P.; Guo, W.; Okoro, O.V.; Sun, Y.; Jiang, G.; Liu, Z.; et al. Fabrication and properties of hydrogel dressings based on genipin crosslinked chondroitin sulfate and chitosan. Polymers 2024, 16, 2876. [Google Scholar] [CrossRef] [PubMed]
  48. Jana, U.K.; Suryawanshi, R.K.; Prajapati, B.P.; Kango, N. Prebiotic mannooligosaccharides: Synthesis, characterization and bioactive properties. Food Chem. 2021, 342, 128328. [Google Scholar] [CrossRef] [PubMed]
  49. Rana, M.; Jassal, S.; Yadav, R.; Sharma, A.; Puri, N.; Mazumder, K.; Gupta, N. Functional β-mannooligosaccharides: Sources, enzymatic production and application as prebiotics. Crit. Rev. Food Sci. Nutr. 2024, 64, 10221–10238. [Google Scholar] [CrossRef]
  50. Kango, N.; Jana, U.K.; Choukade, R.; Nath, S. Advances in prebiotic mannooligosaccharides. Curr. Opin. Food Sci. 2022, 47, 100883. [Google Scholar] [CrossRef]
  51. Jana, U.K.; Kango, N. Characteristics and bioactive properties of mannooligosaccharides derived from agro-waste mannans. Int. J. Biol. Macromol. 2020, 149, 931–940. [Google Scholar] [CrossRef]
  52. Monteagudo-Mera, A.; Rastall, R.A.; Gibson, G.R.; Charalampopoulos, D.; Chatzifragkou, A. Adhesion mechanisms mediated by probiotics and prebiotics and their potential impact on human health. Appl. Microbiol. Biotechnol. 2019, 103, 6463–6472. [Google Scholar] [CrossRef]
  53. Ghosh, A.; Verma, A.K.; Tingirikari, J.R.; Shukla, R.; Goyal, A. Recovery and purification of oligosaccharides from copra meal by recombinant endo-β-mannanase and deciphering molecular mechanism involved and its role as potent therapeutic agent. Mol. Biotechnol. 2015, 57, 111–127. [Google Scholar] [CrossRef]
  54. Comşa, Ş.; Cimpean, A.M.; Raica, M. The story of MCF-7 breast cancer cell line: 40 years of experience in research. Anticancer Res. 2015, 35, 3147–3154. [Google Scholar]
  55. Lee, A.V.; Oesterreich, S.; Davidson, N.E. MCF-7 cells—Changing the course of breast cancer research and care for 45 years. JNCI J. Nat. Cancer Inst. 2015, 107, djv073. [Google Scholar] [CrossRef]
  56. Rajput, A.; Dominguez San Martin, I.; Rose, R.; Beko, A.; LeVea, C.; Sharratt, E.; Mazurchuk, R.; Hoffman, R.M.; Brattain, M.G.; Wang, J. Characterization of HCT116 human colon cancer cells in an orthotopic model. J. Surg. Res. 2008, 147, 276–281. [Google Scholar] [CrossRef]
  57. Pason, P.; Tachaapaikoon, C.; Suyama, W.; Waeonukul, R.; Shao, R.; Wongwattanakul, M.; Limpaiboon, T.; Chonanant, C.; Ngernyuang, N. Anticancer and anti-angiogenic activities of mannooligosaccharides extracted from coconut meal on colorectal carcinoma cells in vitro. Toxicol. Rep. 2024, 12, 82–90. [Google Scholar] [CrossRef] [PubMed]
  58. Tan, S.; Tao, X.; Zheng, P.; Chen, P.; Yu, X.; Li, N.; Gao, T.; Wu, D. Thermostability modification of β-mannanase from Aspergillus niger via flexibility modification engineering. Front. Microbiol. 2023, 14, 1119232. [Google Scholar] [CrossRef] [PubMed]
  59. Nath, S.; Kango, N. Optimized production and characterization of endo-β-mannanase by Aspergillus niger for generation of prebiotic mannooligosaccharides from guar gum. Sci. Rep. 2024, 14, 14015. [Google Scholar] [CrossRef] [PubMed]
  60. Gaspers, P.B.; Robertson, C.R.; Gast, A.P. Enzymes on immobilized substrate surfaces: Diffusion. Langmuir 1994, 10, 2699–2704. [Google Scholar] [CrossRef]
  61. Hamilton, B.K.; Gardner, C.R.; Colton, C.K. Effect of diffusional limitations on lineweaver-burk plots for immobilized enzymes. AIChE J. 1974, 20, 503–510. [Google Scholar] [CrossRef]
  62. Geor malar, C.; Seenuvasan, M.; Kumar, K.S.; Kumar, A.; Parthiban, R. Review on surface modification of nanocarriers to overcome diffusion limitations: An enzyme immobilization aspect. Biochem. Eng. J. 2020, 158, 107574. [Google Scholar] [CrossRef]
  63. e Gomes Silva, N.C.; de Albuquerque, T.L.; Neto, C.A.G.; Gonçalves, L.R.B.; Rocha, M.V.P.; Fernandez-Lafuente, R. Effect of biocatalysts β-galactosidase loading in their performance in the kinetically controlled synthesis of lactulose. Process Biochem. 2024, 146, 169–175. [Google Scholar] [CrossRef]
  64. Mansur, H.S.; Sadahira, C.M.; Souza, A.N.; Mansur, A.A.P. FTIR spectroscopy characterization of poly (vinyl alcohol) hydrogel with different hydrolysis degree and chemically crosslinked with glutaraldehyde. Mater. Sci. Eng. C 2008, 28, 539–548. [Google Scholar] [CrossRef]
  65. Blibech, M.; Mouelhi, S.; Farhat-Khemakhem, A.; Boukhris, I.; Ayeb, A.E.; Chouayekh, H. Selection of Bacillus subtilis US191 as a mannanase-producing probiotic candidate. Biotechnol. Appl. Biochem. 2019, 66, 858–869. [Google Scholar] [CrossRef]
  66. Zhao, D.; Zhang, X.; Wang, Y.; Na, J.; Ping, W.; Ge, J. Purification, biochemical and secondary structural characterisation of β-mannanase from Lactobacillus casei HDS-01 and juice clarification potential. Int. J. Biol. Macromol. 2020, 154, 826–834. [Google Scholar] [CrossRef]
  67. Anderson, A.S.; Mkabayi, L.; Malgas, S.; Kango, N.; Pletschke, B.I. Covalent Immobilisation of an Aspergillus niger Derived Endo-1,4-β-Mannanase, Man26A, on Glutaraldehyde-Activated Chitosan Nanoparticles for the Effective Production of Prebiotic MOS from Soybean Meal. Agronomy 2022, 12, 2993. [Google Scholar] [CrossRef]
  68. Chen, X.; Tian, Z.; Zhou, H.; Zhou, G.; Cheng, H. Enhanced enzymatic performance of β-mannanase immobilized on calcium alginate beads for the generation of mannan oligosaccharides. Foods 2023, 12, 3089. [Google Scholar] [CrossRef]
  69. Chauhan, P.S.; Sharma, P.; Puri, N.; Gupta, N. Purification and characterization of an alkali-thermostable β-mannanase from Bacillus nealsonii PN-11 and its application in mannooligosaccharides preparation having prebiotic potential. Eur. Food Res. Technol. 2014, 238, 927–936. [Google Scholar] [CrossRef]
  70. Sachslehner, A.; Foidl, G.; Foidl, N.; Gübitz, G.; Haltrich, D. Hydrolysis of isolated coffee mannan and coffee extract by mannanases of Sclerotium rolfsii. J. Biotechnol. 2000, 80, 127–134. [Google Scholar] [CrossRef] [PubMed]
  71. Rana, M.; Kumar, D.; Angural, S.; Warmoota, R.; Mazumder, K.; Gupta, N. Hyperproduction of a bacterial mannanase and its application for production of bioactive mannooligosaccharides from agro-waste. Process Biochem. 2023, 124, 13–23. [Google Scholar] [CrossRef]
  72. Erkan, S.B.; Basmak, S.; Ozcan, A.; Yılmazer, C.; Gürler, H.N.; Yavuz, G.; Germec, M.; Yatmaz, E.; Turhan, I. Mannooligosaccharide production by β-mannanase enzyme application from coffee extract. J. Food Process. Preserv. 2021, 45, e14668. [Google Scholar] [CrossRef]
  73. Sawai, S.; Mohktar, M.S.; Safwani, W.; Ramasamy, T.S. Suppression of the viability and proliferation of HepG2 hepatocellular carcinoma cell line by konjac glucomannan. Anticancer Agents Med. Chem. 2018, 18, 1258–1266. [Google Scholar] [CrossRef] [PubMed]
  74. Toprak, A.; Tükel, S.S.; Yildirim, D. Stabilization of multimeric nitrilase via different immobilization techniques for hydrolysis of acrylonitrile to acrylic acid. Biocatal. Biotransform. 2021, 39, 221–231. [Google Scholar] [CrossRef]
  75. Boudrant, J.; Woodley, J.M.; Fernandez-Lafuente, R. Parameters necessary to define an immobilized enzyme preparation. Process Biochem. 2020, 90, 66–80. [Google Scholar] [CrossRef]
  76. Sandhya, T.; Mishra, K.P. Cytotoxic response of breast cancer cell lines, MCF 7 and T 47 D to triphala and its modification by antioxidants. Cancer Lett. 2006, 238, 304–313. [Google Scholar] [CrossRef]
  77. Jiang, F.; Chen, R.; Tang, C.; Li, L.-Q.; Yan, J.-K.; Zhang, H. Polysaccharide extracted from cultivated Sanghuangporous vaninii spores using three-phase partitioning with enzyme/ultrasound pretreatment: Physicochemical characteristics and its biological activity in vitro. Int. J. Biol. Macromol. 2023, 253, 126622. [Google Scholar] [CrossRef]
Molecules 30 04567 g001
Figure 1. Effect of genipin concentration on the activity of PVA@mannanase-Gen. All experiments have been repeated in triplicate. Experiments were performed as described in the Methods section.
Figure 1. Effect of genipin concentration on the activity of PVA@mannanase-Gen. All experiments have been repeated in triplicate. Experiments were performed as described in the Methods section.
Molecules 30 04567 g001
Molecules 30 04567 g002
Figure 2. FTIR spectra of PVA, PVA@mannanase, and PVA@mannanase-Gen at 500–4000 cm−1.
Figure 2. FTIR spectra of PVA, PVA@mannanase, and PVA@mannanase-Gen at 500–4000 cm−1.
Molecules 30 04567 g002
Molecules 30 04567 g003aMolecules 30 04567 g003b
Figure 3. SEM images of PVA (a,b), PVA@mannanase (c,d), and PVA@mannanase-Gen (e,f). Other specifications can be found in the Methods section. The experiments were performed as described in the Methods section.
Figure 3. SEM images of PVA (a,b), PVA@mannanase (c,d), and PVA@mannanase-Gen (e,f). Other specifications can be found in the Methods section. The experiments were performed as described in the Methods section.
Molecules 30 04567 g003aMolecules 30 04567 g003b
Molecules 30 04567 g004aMolecules 30 04567 g004b
Figure 4. Effect of pH on the activity of free mannanase, PVA@mannanase, and PVA@mannanase-Gen at 40 °C and 0.25% (w/v) LBG concentration (A). Effect of temperature on the activity of free mannanase, PVA@mannanase, and PVA@mannanase-Gen at pH 5.0 and 0.25% (w/v) LBG concentration (B). Thermal stability of free mannanase, PVA@mannanase, and PVA@mannanase-Gen at 40 °C (C) and 55 °C (D) at pH 5.0. All experiments have been repeated in triplicate. Other specifications may be found in the Methods section.
Figure 4. Effect of pH on the activity of free mannanase, PVA@mannanase, and PVA@mannanase-Gen at 40 °C and 0.25% (w/v) LBG concentration (A). Effect of temperature on the activity of free mannanase, PVA@mannanase, and PVA@mannanase-Gen at pH 5.0 and 0.25% (w/v) LBG concentration (B). Thermal stability of free mannanase, PVA@mannanase, and PVA@mannanase-Gen at 40 °C (C) and 55 °C (D) at pH 5.0. All experiments have been repeated in triplicate. Other specifications may be found in the Methods section.
Molecules 30 04567 g004aMolecules 30 04567 g004b
Molecules 30 04567 g005
Figure 5. Reuse stability of PVA@mannanase and PVA@mannanase-Gen at pH 5.0 and 55 °C. All experiments have been repeated in triplicate. Other specifications may be found in the Methods section.
Figure 5. Reuse stability of PVA@mannanase and PVA@mannanase-Gen at pH 5.0 and 55 °C. All experiments have been repeated in triplicate. Other specifications may be found in the Methods section.
Molecules 30 04567 g005
Molecules 30 04567 g006
Figure 6. The time-course hydrolysis of LGB (0.25%, w/v) catalyzed by PVA@mannanase-Gen at pH 5.0 and 55 °C. The amount of formed MOSs (A) and MOS products (B). All experiments have been repeated in triplicate.
Figure 6. The time-course hydrolysis of LGB (0.25%, w/v) catalyzed by PVA@mannanase-Gen at pH 5.0 and 55 °C. The amount of formed MOSs (A) and MOS products (B). All experiments have been repeated in triplicate.
Molecules 30 04567 g006
Molecules 30 04567 g007
Figure 7. Effect of MOS concentration on viability of MCF-7 and HCT-116 cell lines. Other specifications may be found in the Methods section. All experiments have been repeated in triplicate.
Figure 7. Effect of MOS concentration on viability of MCF-7 and HCT-116 cell lines. Other specifications may be found in the Methods section. All experiments have been repeated in triplicate.
Molecules 30 04567 g007
Table 1. Immobilization yields and activity of recovery values of PVA@mannanase and PVA@mannanase-Gen for different protein loadings. Other specifications can be found in the Methods section.
Table 1. Immobilization yields and activity of recovery values of PVA@mannanase and PVA@mannanase-Gen for different protein loadings. Other specifications can be found in the Methods section.
Loaded Protein Concentration (mg/mL)Immobilization Yield
(%)		Expressed Activity
(mannanase-Gen)
(%)		Expressed Activity
(PVA@mannanase)
(%)		Expressed Activity
(PVA@mannanase-Gen)
(%)
0.125100125.234.845.2
0.25100122.386.6119.2
0.5100110.123.228.6
Table 2. The apparent kinetic parameters of free mannanase, PVA@mannanase, and PVA@mannanase-Gen for LBG at optimal pH and temperature of each preparation.
Table 2. The apparent kinetic parameters of free mannanase, PVA@mannanase, and PVA@mannanase-Gen for LBG at optimal pH and temperature of each preparation.
BiocatalystKm
(mg mL−1)		Vmax
(U/mg Protein)		Catalytic Efficiency RatioReference
MC8.11350.50[25]
MB-C6.767.10.37[25]
Free 1,4-β-mannanase10.7106 [27]
Man/Cel5B4.82.560.05[27]
Free 1,4-β-mannanase8.4455.36 [67]
Immobilized on glutaraldehyde-activated chitosan nanoparticles7.7412.100.24[67]
Free 1,4-β-mannanase252500 [28]
NaAlg-β-CD-β-mannanase362252.250.63[28]
Free 1,4-β-mannanase10.23.24 [68]
Man-CaAlg19.46.171.0[68]
Free mannanase25.8 ± 0.0455.0 ± 0.07-This study
PVA@mannanase69.6 ± 0.0534.4 ± 0.080.24This study
PVA@mannanase-Gen14.0 ± 0.0368.9 ± 0.062.30This study
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Faki, N.E.V.; Toprak, A.; Yucebilgic, G.; Alagöz, D.; Yildirim, D.; Fernandez-Lafuente, R. Enhancing the Catalytic Performance of β-Mannanase via Polyvinyl Alcohol Immobilization and Genipin Modification. Molecules 2025, 30, 4567. https://doi.org/10.3390/molecules30234567

AMA Style

Faki NEV, Toprak A, Yucebilgic G, Alagöz D, Yildirim D, Fernandez-Lafuente R. Enhancing the Catalytic Performance of β-Mannanase via Polyvinyl Alcohol Immobilization and Genipin Modification. Molecules. 2025; 30(23):4567. https://doi.org/10.3390/molecules30234567

Chicago/Turabian Style

Faki, Nazli Ece Varan, Ali Toprak, Guzide Yucebilgic, Dilek Alagöz, Deniz Yildirim, and Roberto Fernandez-Lafuente. 2025. "Enhancing the Catalytic Performance of β-Mannanase via Polyvinyl Alcohol Immobilization and Genipin Modification" Molecules 30, no. 23: 4567. https://doi.org/10.3390/molecules30234567

APA Style

Faki, N. E. V., Toprak, A., Yucebilgic, G., Alagöz, D., Yildirim, D., & Fernandez-Lafuente, R. (2025). Enhancing the Catalytic Performance of β-Mannanase via Polyvinyl Alcohol Immobilization and Genipin Modification. Molecules, 30(23), 4567. https://doi.org/10.3390/molecules30234567

Article Metrics

Back to TopTop